United Gene International Holdings Group Limited - Net Worth and Insider Trading

United Gene International Holdings Group Limited Net Worth

The estimated net worth of United Gene International Holdings Group Limited is at least $44 Million dollars as of 2024-11-13. United Gene International Holdings Group Limited is the 2101 Beneficial owner of Extrawell Pharmaceutical Holdings Ltd and owns about 900,000,000 shares of Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) stock worth over $44 Million. Details can be seen in United Gene International Holdings Group Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that United Gene International Holdings Group Limited has not made any transactions after 2019-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of United Gene International Holdings Group Limited

United Gene International Holdings Group Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, United Gene International Holdings Group Limited owns 1 companies in total, including Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) .

Click here to see the complete history of United Gene International Holdings Group Limited’s form 4 insider trades.

Insider Ownership Summary of United Gene International Holdings Group Limited

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:00858	Extrawell Pharmaceutical Holdings Ltd	2019-12-23	2101 Beneficial owner

United Gene International Holdings Group Limited Latest Holdings Summary

United Gene International Holdings Group Limited currently owns a total of 1 stock. United Gene International Holdings Group Limited owns 900,000,000 shares of Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) as of December 23, 2019, with a value of $44 Million.

Latest Holdings of United Gene International Holdings Group Limited

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:00858	Extrawell Pharmaceutical Holdings Ltd	2019-12-23	900,000,000	0.05	44,100,000

Holding Weightings of United Gene International Holdings Group Limited

United Gene International Holdings Group Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, United Gene International Holdings Group Limited has made a total of 1 transactions in Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Extrawell Pharmaceutical Holdings Ltd is the sale of 900,000,000 shares on December 23, 2019, which brought United Gene International Holdings Group Limited around $0.

Insider Trading History of United Gene International Holdings Group Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

United Gene International Holdings Group Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

United Gene International Holdings Group Limited Ownership Network

Ownership Network List of United Gene International Holdings Group Limited

No Data

Ownership Network Relation of United Gene International Holdings Group Limited

United Gene International Holdings Group Limited Owned Company Details

What does Extrawell Pharmaceutical Holdings Ltd do?

Who are the key executives at Extrawell Pharmaceutical Holdings Ltd?

United Gene International Holdings Group Limited is the 2101 Beneficial owner of Extrawell Pharmaceutical Holdings Ltd. Other key executives at Extrawell Pharmaceutical Holdings Ltd include 2201 Interest of corporation controlled by you Mao Yumin , 2201 Interest of corporation controlled by you Biowindow Gene Development (hong Kong) Limited , and 2201 Interest of corporation controlled by you Ease Gold Investments Limited .

Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Extrawell Pharmaceutical Holdings Ltd (HKSE:00858) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Extrawell Pharmaceutical Holdings Ltd (HKSE:00858)'s detailed insider trading history can be found in Insider Trading Tracker table.

Extrawell Pharmaceutical Holdings Ltd Insider Transactions

No Available Data

United Gene International Holdings Group Limited Mailing Address

Above is the net worth, insider trading, and ownership report for United Gene International Holdings Group Limited. Currently GuruFocus does not have mailing address information for United Gene International Holdings Group Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.